GSK Community

March Madness is here, or so they say on the basketball courts. But Marchs madness is slowly moving off to more than just the courts.

Key Takeaways Escalating pricing pressures and patent expirations threaten growth, margins, and the value from new and existing products across key markets. Weak R&D productivity, mounting legal risks, and emerging market volatility undermine earnings stability and long-term strategic goals.

Key Takeaways Accelerated advancement in specialty medicines, vaccines, and anti-infective therapies positions GSK for outsized revenue and margin growth relative to peers. Strategic investments in digital capabilities and global scale enhance productivity, unlock new markets, and support long-term, defensible earnings streams.

Key Takeaways Robust growth in vaccines and specialty medicines, alongside innovation in oncology and immunology, positions GSK for sustained revenue and margin expansion. Diversification, operational efficiencies, and accelerated R&D enhance resilience, supporting strong long-term sales and earnings potential despite industry pressures.